Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 31.00
-0.05 (-0.16%)
At close: Aug 1, 2025
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 4.68 billion as of August 1, 2025. Its market cap has decreased by -36.45% in one year.
Market Cap
4.68B
Enterprise Value
3.11B
Revenue
16.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.00
Market Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 4.68B, a decrease of -15.44%. That is a compound annual growth rate of -4.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 4.68B | -17.22% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
| Oct 7, 2021 | 5.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 191.55B |
| PharmaEssentia | 165.30B |
| Bora Pharmaceuticals Co., LTD. | 85.03B |
| Lotus Pharmaceutical | 57.32B |
| Oneness Biotech | 30.42B |
| Polaris Group | 27.66B |
| Center Laboratories | 26.57B |
| Pegavision | 24.02B |